A link between abnormal blood levels of amyloid -- a protein associated with Alzheimer's disease -- and subtle changes in brain microstructures on a type of MRI could lead to a new way to detect ...

Emory researchers discovered blood changes that could allow Alzheimer’s to be detected years before symptoms appear. The team is developing a blood test that may identify early risk and guide ...

PET scans can detect amyloid plaques and tau tangles in the brain, which are often early signs of Alzheimer’s disease. But they’re not enough on their own to make a diagnosis. Alzheimer’s disease is ...

New findings out of Emory University are challenging existing theories about the origins of Alzheimer's, the leading cause of dementia in the elderly worldwide. A team led by researchers at the ...

Findings suggest the test can reduce the need for PET imaging in some patients with mild cognitive decline to enable therapeutic focus on non-Alzheimer's disease causes, broadening access to quality ...

New criteria could lead to a diagnosis on the basis of a simple blood test, even in the absence of obvious symptoms. By Paula Span Determining whether someone has Alzheimer’s disease usually requires ...

Please provide your email address to receive an email when new articles are posted on . C 2 N Diagnostics released the PrecivityAD2 blood test, which uses positron emission tomography scans and ...

The FDA cleared its first in vitro test to help determine whether people showing signs of cognitive decline also carry one of the hidden hallmarks of Alzheimer’s disease. The diagnostic detects ...

A new generation of blood tests is poised to change the way doctors determine whether patients with memory loss also have Alzheimer's disease. The tests detect substances in the blood that indicate ...